MedTrace Logo

Validation of Questionnaires HAL and HEP

NCT02512211 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-07-01

No results posted yet for this study

Summary

Spanish Validation of HAL and HEP questionnaire by double translation (English-Spanish-English), with a pilotage pediatric patients with hemophilia and adults and parents of children with hemophilia. The final validity will be obtained with a sample of 60-100 patients with hemophilia

Conditions

  • Haemophilia

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Principal Investigators

  • RUBEN CUESTA-BARRIUSO, PhD · Universidad Católica San Antonio

Eligibility

Min Age
8 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-05-31
Completion
2016-10-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02512211 on ClinicalTrials.gov